Trastuzumab Industry in China 2018

1
Investigation Report on China Trastuzumab Market,
2009-2018byResearch In China

• Explore all reports for Life Sciences market
• _at_ http//www.chinamarketresearchreports.com/cat/li
  fe-sciences.html .

2
Investigation Report on China Trastuzumab Market,
2009-2018

• The collection of Life Sciences market research
  reports has a new addition of Investigation
  Report on China Trastuzumab Market, 2009-2018On
  chinamarketresearchreports.com. Trastuzumab is a
  monoclonal antibody that interferes with the
  HER2/neu receptor. Its main use is to treat
  certain breast cancers. Trastuzumab has a major
  impact in the treatment of HER2positive
  metastatic breast cancers.
• In China, less than 10 of women can get mammary
  diseases inspection every year for the limitation
  of medical conditions and lack of knowledge.
  Therefore, only 20 of breast cancers is detected
  at an early stage in China while 80 is detected
  at an early stage in the U.S.A.
• The incidence of breast cancers ranks the first
  in malignant tumors. According to incomplete
  statistics, the incidence number of breast
  cancers exceeds 200,000 every year in China. By
  the end of 2013, the number of living breast
  cancer patients exceeded 500,000, above 1/3 of
  which were metastatic breast cancers. The
  incidence and mortality rates of breast cancers
  differ from urban to rural areas in China.
• Inquire for discount _at_ http//www.chinamarketresea
  rchreports.com/contacts/inquiry.php?name114713

3
Investigation Report on China Trastuzumab Market,
2009-2018

• In recent 10 years, the incidence of breast
  cancers in cities obviously increases but the
  mortality rate remains stable. However, the
  incidence and mortality rates of breast cancers
  in rural areas present obvious uprising trend.
  The number of breast cancer patients in cities is
  increasing, especially in young women groups. It
  is mainly caused by the change of lifestyle and
  diet habits and the incidence growth of other
  mammary diseases like fibroma. Take Fujian as an
  instance, from 1970s to the early 21 century, the
  mortality rate of breast cancers in Fujian
  presents an upward trend. The mortality rates in
  19731975, 19901992 and 20042005 are separately
  31.6/million, 34.2/million and 44.6/million. In
  2011, the mortality rate of women breast cancer
  patients was 70.7/million in Fujian. Obviously,
  the mortality rate doubled during 20052011.
• In China sample hospital market, the market share
  of trastuzumab is completely taken by Shanghai
  Roche and GENENTECH. During 20052013, the CAGR of
  market size of trastuzumab in sample hospitals
  exceeded 60. The unit retail price maintains CNY
  20,000 (USD 3,300) or more.
• Complete report is available _at_
  http//www.chinamarketresearchreports.com/114713.h
  tml

4
Investigation Report on China Trastuzumab Market,
2009-2018

• The patent of trastuzumab will expire in 2014.
  The huge profit margin and market potential
  attract many generic drug manufacturers. CRI sees
  many generic drugs will enter global market after
  2015. According to CRI's investigation, many
  generic drug companies add trastuzumab to the RD
  list, some of which has certain achievements.
• Through this report, the readers can acquire the
  following information
• Market Share of Major Trastuzumab Manufacturers
  in Sample Hospitals in China
• Sales price of Trastuzumab in Hospital Market in
  China
• Major Trastuzumab enterprises in China
• Market share of Trastuzumab by dosage form in
  hospital market in China
• Incidence of breast cancers in China
• Progress of trastuzumab generic drugs
• Prospect of China trastuzumab market
• Inquire for discount _at_ http//www.chinamarketresea
  rchreports.com/contacts/inquiry.php?name114713

5
Investigation Report on China Trastuzumab Market,
2009-2018

• The following enterprises and people are
  recommended to purchase this report
• Trastuzumab API and finished product
  manufacturers
• Medical Institutions
• Investors/research agencies focusing on
  trastuzumab market
• Table of Contents
• 1 Relevant Concepts of Trastuzumab1.1
  Indication1.2 Sales Status on the Global Market
• 2 Market Overview of Trastuzumab in China,
  2009-20132.1 Patent Status2.2 Major
  Manufacturers2.3 Market Size
• 3 Investigation on Sales Value of Trastuzumab in
  China, 2009-20133.1 Total Sales ValueComplete
  report is available _at_ http//www.chinamarketresea
  rchreports.com/114713.html

6
Investigation Report on China Trastuzumab Market,
2009-2018

• 4 Investigation on Market Share of Major
  Trastuzumab Manufacturers in China, 2009-20134.1
  Market Share by Sales Value4.2 Market Share by
  Sales Volume
• 5 Investigation on Market Size of Trastuzumab by
  Dosage Form in China , 2009-20135.1 Market Share
  by Sales Value and Dosage Form5.2 Market Share
  by Sales Volume and Dosage Form
• 6 Reference Price of Trastuzumab in Hospital
  Market in China, 20136.1 Trastuzumab Produced by
  Shanghai Roche (Brand Name Herceptin)6.2
  Trastuzumab Produced by GENENTECH (Brand Name
  Herceptin)
• 7 Analysis on Major Trastuzumab Manufacturers in
  China, 2009-20137.1 Shanghai Roche
  Pharmaceuticals Ltd.7.2 GENENTECH (Subsidiary of
  Roche)
• Inquire for discount _at_ http//www.chinamarketresea
  rchreports.com/contacts/inquiry.php?name114713

7
Investigation Report on China Trastuzumab Market,
2009-2018

• 8 Prospect of China Trastuzumab Market,
  2014-20188.1 Forecast on Incidence of Mammary
  Cancer8.2 Forecast on Market Size8.3 Forecast
  on Competition Pattern
• List of Charts
• Chart Trastuzumab Products Approved to Market in
  China, 2014Chart Forecast on Market Size of
  Hospital-use Trastuzumab in China,
  2014-2018Chart Sales Value of Trastuzumab in
  Global Market, 2009-2013Chart Sales Value of
  Trastuzumab in Hospital Market in China,
  2009-2013Chart Sales Value of Trastuzumab by
  Region in China, 2009-2013Chart Market Share of
  Trastuzumab Enterprises by Sales Value in China,
  2009-2013Chart Price of Trastuzumab Produced by
  GENENTECH(US) in Hospital Market, 2009-2013Chart
  Price of Trastuzumab Produced by Shanghai Roche
  in Hospital
• Complete report is available _at_
  http//www.chinamarketresearchreports.com/114713.h
  tml

8
Investigation Report on China Trastuzumab Market,
2009-2018